The company’s flagship da Vinci robotic surgery system was 1st developed for the U.S. Army in the late 1980s at the former Stanford Research Institute. Although the Army hoped it would result in a remotely operated device for battlefield surgery, the commercial applications were too compelling to ignore. Intuitive was founded in 1995 and launched the da Vinci Surgical System 4 years later. The FDA cleared the device for general laparoscopic surgery in 2000; FDA nods for thoracoscopic, cardiac, urologic, gynecologic, pediatric and transoral otolaryngology procedures followed. ISRG went public in June 2000 at $9 per share; today – after another IPO and the acquisition of its principal competitor, Computer Motion, in 2003 – the stock has traded above the $455-per-share mark all year.
Home » Intuitive Surgical
More recent news
- Medtronic launches spinal system for deformity procedures
- First patient enrolled in IDE study of Conformal Medical’s next-gen LAAO device
- Biotronik, Egg Medical collaborate to protect healthcare workers from radiation
- VitalConnect raises $100M for biosensor tech for cardiac monitoring
- Lifeward CEO plans to retire